<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="3206">
  <stage>Registered</stage>
  <submitdate>21/06/2011</submitdate>
  <approvaldate>21/06/2011</approvaldate>
  <nctid>NCT01379326</nctid>
  <trial_identification>
    <studytitle>Monitoring the Efficacy of Anthelmintics for the Treatment of Soil Transmitted Helminths P2</studytitle>
    <scientifictitle>The Efficacy of a Single-dose Mebendazole Against Soil-transmitted Helminths in School Children</scientifictitle>
    <utrn />
    <trialacronym>ConWorm</trialacronym>
    <secondaryid>2011/374</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Ascaris Lumbricoides</healthcondition>
    <healthcondition>Ascaris Suum</healthcondition>
    <healthcondition>Trichuris Trichiura</healthcondition>
    <healthcondition>Trichuris Vulpis</healthcondition>
    <healthcondition>Ancylostoma Duodenal</healthcondition>
    <healthcondition>Ancylostoma Caninum</healthcondition>
    <healthcondition>Ancylostoma Ceylanicum</healthcondition>
    <healthcondition>Necator Americanus</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Mebendazole

Experimental: Mebendazole - 


Treatment: drugs: Mebendazole
All children providing stool samples will be treated with mebendazole single table of 500mg under supervision (chewing + water).

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Reduction of fecal egg counts at 14 days post-intervention. - Fecal egg counts at intervention and at 14 days follow-up.</outcome>
      <timepoint>At 14 days post-intervention.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Distribution of hookworms species. - Presence of zoonotic Soil-Transmitted Helminths species, mutations linked with anthelminthic resistance.</outcome>
      <timepoint>Samples will be collected at 14 days of follow-up.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria />
    <inclusiveminage>4</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>18</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Subjects who are unable to provide a stool sample at follow-up

          -  Subjects who are experiencing a severe concurrent medical condition

          -  Subjects with diarrhea at first sampling</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/12/2011</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>250</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/12/2012</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>Commonwealth Scientific and Industrial Research Organisation - Brisbane</hospital>
    <hospital>Queensland Institute for Medical Research, University of Queensland - Herston QLD</hospital>
    <postcode> - Brisbane</postcode>
    <postcode> - Herston QLD</postcode>
    <countryoutsideaustralia>
      <country>Argentina</country>
      <state>Buenos Aires</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state>Belo Horizonte</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Cambodia</country>
      <state>Phnom Penh</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Cameroon</country>
      <state>Yaoundé I</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Ethiopia</country>
      <state>Jimma</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Tanzania</country>
      <state>Zanzibar</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Vietnam</country>
      <state>Hanoi</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>University Ghent</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Commonwealth Scientific and Industrial Research Organisation, Australia</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>World Health Organization</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Institut Pasteur, Cambodia</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>The University of Queensland</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Oswaldo Cruz Foundation</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>University of Nottingham</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>University of Yaounde 1</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Ivo de Carneri, Pemba Island, Tanzania</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>National Institute of Malariology, Parasitology and Entomology, Vietnam</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Jimma University</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>The Huesped Foundation</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Queensland Institute of Medical Research</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Commercial sector/Industry</othercollaboratortype>
      <othercollaboratorname>Institut Pasteur</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Objectives:

      The overall objective is to monitor efficacy of mebendazole (MBZ) against Soil-Transmitted
      Helminths (STH).

      The primary objective is:

      (1) to monitor the efficacy a single dose 500 mg of mebendazole (MBZ) against
      Soil-Transmitted Helminths (STH) infections by means of Faecal Egg Count Reduction (FECR) and
      Cure Rate (CR).

      The secondary objectives are:

        1. to assess the occurrence of Necator americanus and Ancylostoma duodenal.

        2. to assess the occurrence of ß-tubulin mutations related to resistance before and after
           drug administration.

        3. to evaluate the role of dogs and pigs as reservoir for zoonotic transmission.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01379326</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>